microRNAs and their therapeutic strategy in phase I and phase II clinical trials.
Epigenomics
; 16(4): 259-271, 2024 Feb.
Article
em En
| MEDLINE
| ID: mdl-38312027
ABSTRACT
miRNAs play a crucial therapeutic role in diseases such as cancer, diabetes and viral infections, with around 1900 identified in the human genome. Some have progressed to clinical trials, and miRNA mimics and miRNA inhibitors are pivotal therapeutic molecules undergoing evaluation. The review delves into various miRNA-associated clinical trials, emphasizing their precision in targeting specific genes, modulating disease pathways and diagnostic potential. This underscores the importance of miRNA therapy, foreseeing innovations in precision medicine techniques for diverse diseases. The future envisions improved delivery systems addressing challenges like immunogenicity and digestion, while a comprehensive miRNA-based omics database could guide the development of tailored antisense miRNAs, further advancing precision medicine strategies.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Viroses
/
MicroRNAs
/
Neoplasias
Limite:
Humans
Idioma:
En
Revista:
Epigenomics
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Índia